CALLUNA PHARMA AS
932255189ActiveClinical stage biotech pioneering antibodies for inflammation and fibrosis.
Yleiskatsaus
- 10
- Työntekijät
- 26.9milj NOK
- Liikevaihto
- 2023
- Perustettu
Avainpäättäjät
Susanne Stuffers MD PhD
Board member
Caroline Kurtz
Chief Scientific Officer
Gijs van den Brink MD PhD
Board member
Vincent Loon
Observer to the Board
+15 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Calluna Pharma is a global biotechnology company specializing in developing therapeutics focused on inflammation and fibrosis. Driven by a lean, committed team, the company is currently in the clinical stage of development. Their innovative approach targets upstream disease amplifiers using first-in...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- Aksjeselskap
- ALV-numero
- Tuntematon
Päättäjät
19 yhteystietoa FunnelfeedrissäSusanne Stuffers MD PhD
Board member
Caroline Kurtz
Chief Scientific Officer
Gijs van den Brink MD PhD
Board member
Vincent Loon
Observer to the Board
Farzad Abdi-Dezfuli PhD
Board member
Mark Gaffney
Chief Executive Officer and member of the Board
Mark Altmeyer
Chair person
Marco Boorsma
Board member
Jonas Hallén
Chief Medical Officer
Jonas Hallén MD PhD
Chief Medical Officer
Margrethe Sørgaard
SVP Clinical Operations and Pharmacovigilance
Berte Poulsson
SVP Operations
Farzad Abdi-Dezfuli
Board member
Anjeza Gjino
Chief Financial Officer
Susanne Stuffers
Board member
Gijs van den Brink
Board member
Marco Boorsma PhD
Board member
Birgitte Gangmark Villmo
Observer to the Board
Muut yhteyshenkilöt
Benjamin Dyhre
Author
Samankaltaiset yritykset
20 samankaltaista yritystä Funnelfeedrissä
ScandiBio Therapeutics AB
0 työntekijätAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
Cereno Scientific AB
10–19 työntekijätPioneering disease-modifying treatments for rare cardiovascular and pulmonary diseases.
Vicore Pharma Holding AB
5–9 työntekijätDeveloping novel ATRAG drugs for severe respiratory diseases.
CANTARGIA AB
20–49 työntekijätDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
Vicore Pharma AB
5–9 työntekijätInnovative clinical-stage pharma developing severe lung disease treatments.
Selaa lisää
Kysymyksiä yrityksestä CALLUNA PHARMA AS
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo